IBDEI14L ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,18800,0)
 ;;=I09.89^^94^915^17
 ;;^UTILITY(U,$J,358.3,18800,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18800,1,3,0)
 ;;=3^Rheumatic Heart Diseases NEC
 ;;^UTILITY(U,$J,358.3,18800,1,4,0)
 ;;=4^I09.89
 ;;^UTILITY(U,$J,358.3,18800,2)
 ;;=^5007060
 ;;^UTILITY(U,$J,358.3,18801,0)
 ;;=I47.1^^94^915^24
 ;;^UTILITY(U,$J,358.3,18801,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18801,1,3,0)
 ;;=3^Supraventricular Tachycardia
 ;;^UTILITY(U,$J,358.3,18801,1,4,0)
 ;;=4^I47.1
 ;;^UTILITY(U,$J,358.3,18801,2)
 ;;=^5007223
 ;;^UTILITY(U,$J,358.3,18802,0)
 ;;=I48.0^^94^915^15
 ;;^UTILITY(U,$J,358.3,18802,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18802,1,3,0)
 ;;=3^Paroxysmal Atrial Fibrillation
 ;;^UTILITY(U,$J,358.3,18802,1,4,0)
 ;;=4^I48.0
 ;;^UTILITY(U,$J,358.3,18802,2)
 ;;=^90473
 ;;^UTILITY(U,$J,358.3,18803,0)
 ;;=I49.5^^94^915^23
 ;;^UTILITY(U,$J,358.3,18803,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18803,1,3,0)
 ;;=3^Sick Sinus Syndrome
 ;;^UTILITY(U,$J,358.3,18803,1,4,0)
 ;;=4^I49.5
 ;;^UTILITY(U,$J,358.3,18803,2)
 ;;=^110404
 ;;^UTILITY(U,$J,358.3,18804,0)
 ;;=I49.8^^94^915^3
 ;;^UTILITY(U,$J,358.3,18804,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18804,1,3,0)
 ;;=3^Cardiac Arrhythmias
 ;;^UTILITY(U,$J,358.3,18804,1,4,0)
 ;;=4^I49.8
 ;;^UTILITY(U,$J,358.3,18804,2)
 ;;=^5007236
 ;;^UTILITY(U,$J,358.3,18805,0)
 ;;=I49.9^^94^915^2
 ;;^UTILITY(U,$J,358.3,18805,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18805,1,3,0)
 ;;=3^Cardiac Arrhythmia,Unspec
 ;;^UTILITY(U,$J,358.3,18805,1,4,0)
 ;;=4^I49.9
 ;;^UTILITY(U,$J,358.3,18805,2)
 ;;=^5007237
 ;;^UTILITY(U,$J,358.3,18806,0)
 ;;=R00.1^^94^915^1
 ;;^UTILITY(U,$J,358.3,18806,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18806,1,3,0)
 ;;=3^Bradycardia,Unspec
 ;;^UTILITY(U,$J,358.3,18806,1,4,0)
 ;;=4^R00.1
 ;;^UTILITY(U,$J,358.3,18806,2)
 ;;=^5019164
 ;;^UTILITY(U,$J,358.3,18807,0)
 ;;=I34.1^^94^915^14
 ;;^UTILITY(U,$J,358.3,18807,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18807,1,3,0)
 ;;=3^Nonrheumatic Mitral Valve Prolapse
 ;;^UTILITY(U,$J,358.3,18807,1,4,0)
 ;;=4^I34.1
 ;;^UTILITY(U,$J,358.3,18807,2)
 ;;=^5007170
 ;;^UTILITY(U,$J,358.3,18808,0)
 ;;=D68.4^^94^916^1
 ;;^UTILITY(U,$J,358.3,18808,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18808,1,3,0)
 ;;=3^Acquired Coagulation Factor Deficiency
 ;;^UTILITY(U,$J,358.3,18808,1,4,0)
 ;;=4^D68.4
 ;;^UTILITY(U,$J,358.3,18808,2)
 ;;=^2235
 ;;^UTILITY(U,$J,358.3,18809,0)
 ;;=D59.9^^94^916^2
 ;;^UTILITY(U,$J,358.3,18809,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18809,1,3,0)
 ;;=3^Acquired Hemolytic Anemia,Unspec
 ;;^UTILITY(U,$J,358.3,18809,1,4,0)
 ;;=4^D59.9
 ;;^UTILITY(U,$J,358.3,18809,2)
 ;;=^5002330
 ;;^UTILITY(U,$J,358.3,18810,0)
 ;;=C91.00^^94^916^5
 ;;^UTILITY(U,$J,358.3,18810,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18810,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,Not in Remission
 ;;^UTILITY(U,$J,358.3,18810,1,4,0)
 ;;=4^C91.00
 ;;^UTILITY(U,$J,358.3,18810,2)
 ;;=^5001762
 ;;^UTILITY(U,$J,358.3,18811,0)
 ;;=C91.01^^94^916^4
 ;;^UTILITY(U,$J,358.3,18811,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18811,1,3,0)
 ;;=3^Acute Lymphoblastic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,18811,1,4,0)
 ;;=4^C91.01
 ;;^UTILITY(U,$J,358.3,18811,2)
 ;;=^5001763
 ;;^UTILITY(U,$J,358.3,18812,0)
 ;;=C92.01^^94^916^7
 ;;^UTILITY(U,$J,358.3,18812,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,18812,1,3,0)
 ;;=3^Acute Myeloblastic Leukemia,In Remission
 ;;^UTILITY(U,$J,358.3,18812,1,4,0)
 ;;=4^C92.01
 ;;^UTILITY(U,$J,358.3,18812,2)
 ;;=^5001790
 ;;^UTILITY(U,$J,358.3,18813,0)
 ;;=C92.00^^94^916^8
